[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100054111":3},{"organization":4,"armGroups":7,"interventions":22,"overallOfficials":27,"centralContacts":34,"locations":40,"responsibleParty":111,"collaborators":27,"id":113,"slug":114,"hasResults":115,"nctId":116,"briefTitle":117,"officialTitle":118,"acronym":27,"eligibilityCriteria":119,"healthyVolunteers":115,"sex":120,"minAge":121,"maxAge":122,"enrollmentInfo":123,"targetDuration":27,"studyType":126,"phases":127,"briefSummary":130,"conditions":131,"keywords":27,"overallStatus":43,"whyStopped":27,"lastUpdateSubmitDate":135,"lastUpdatePostDateStruct":136,"startDateStruct":139,"completionDateStruct":141,"leadSponsor":143,"locationsCount":144},{"fullName":5,"class":6},"TORL Biotherapeutics, LLC","INDUSTRY",[8,14,18],{"label":9,"type":10,"description":11,"interventionNames":12},"Treatment Arm A: TORL-1-23 and paclitaxel","EXPERIMENTAL","Administered once every three weeks",[13],"Combination Product: TORL-1-23 and paclitaxel",{"label":15,"type":10,"description":11,"interventionNames":16},"Treatment Arm B: TORL-1-23 and carboplatin",[17],"Combination Product: TORL-1-23 and carboplatin",{"label":19,"type":10,"description":11,"interventionNames":20},"Treatment Arm C: TORL-1-23, paclitaxel, and carboplatin",[21],"Combination Product: TORL-1-23, paclitaxel, and carboplatin",[23,28,31],{"type":24,"name":25,"description":25,"armGroupLabels":26,"otherNames":27},"COMBINATION_PRODUCT","TORL-1-23 and paclitaxel",[9],null,{"type":24,"name":29,"description":29,"armGroupLabels":30,"otherNames":27},"TORL-1-23 and carboplatin",[15],{"type":24,"name":32,"description":32,"armGroupLabels":33,"otherNames":27},"TORL-1-23, paclitaxel, and carboplatin",[19],[35],{"name":36,"role":37,"phone":38,"phoneExt":27,"email":39},"Caroline Labib, PharmD","CONTACT","310-348-9636","caroline.labib@torlbio.com",[41,55,64,73,82,92,101],{"facility":42,"status":43,"city":44,"state":45,"zip":46,"country":47,"countryCode":48,"cosmosGeoPoint":49,"geoPoint":54,"contacts":27},"Providence St. Jude Medical Center","RECRUITING","Fullerton","California","92835","United States","US",{"type":50,"coordinates":51},"Point",[52,53],-117.92534,33.87029,{"lat":53,"lon":52},{"facility":56,"status":43,"city":57,"state":45,"zip":58,"country":47,"countryCode":48,"cosmosGeoPoint":59,"geoPoint":63,"contacts":27},"City of Hope","Irvine","92618",{"type":50,"coordinates":60},[61,62],-117.82311,33.66946,{"lat":62,"lon":61},{"facility":65,"status":43,"city":66,"state":45,"zip":67,"country":47,"countryCode":48,"cosmosGeoPoint":68,"geoPoint":72,"contacts":27},"University of Southern California","Los Angeles","90007",{"type":50,"coordinates":69},[70,71],-118.24368,34.05223,{"lat":71,"lon":70},{"facility":74,"status":43,"city":66,"state":45,"zip":75,"country":47,"countryCode":48,"cosmosGeoPoint":76,"geoPoint":78,"contacts":79},"UCLA","90095",{"type":50,"coordinates":77},[70,71],{"lat":71,"lon":70},[80],{"name":81,"role":37,"phone":38,"phoneExt":27,"email":27},"Principal Investigator",{"facility":83,"status":43,"city":84,"state":85,"zip":86,"country":47,"countryCode":48,"cosmosGeoPoint":87,"geoPoint":91,"contacts":27},"The Mayo Clinic","Rochester","Minnesota","55905",{"type":50,"coordinates":88},[89,90],-92.4699,44.02163,{"lat":90,"lon":89},{"facility":93,"status":43,"city":94,"state":94,"zip":95,"country":47,"countryCode":48,"cosmosGeoPoint":96,"geoPoint":100,"contacts":27},"Mt Sinai Hospital","New York","10029",{"type":50,"coordinates":97},[98,99],-74.00597,40.71427,{"lat":99,"lon":98},{"facility":102,"status":43,"city":103,"state":104,"zip":105,"country":47,"countryCode":48,"cosmosGeoPoint":106,"geoPoint":110,"contacts":27},"Duke University","Durham","North Carolina","27705",{"type":50,"coordinates":107},[108,109],-78.89862,35.99403,{"lat":109,"lon":108},{"type":112,"investigatorFullName":27,"investigatorTitle":27,"investigatorAffiliation":27,"oldNameTitle":27,"oldOrganization":27},"SPONSOR","100054111","phase-1-catalina-4-a-study-to-investigate-the-safety-and-efficacy-of-torl-1-23-with-chemotherapy-given-before-initial-surgery-in-women-with-advanced-stage-ovarian-cancer-100054111",false,"NCT07322094","CATALINA-4: A Study to Investigate the Safety and Efficacy of TORL-1-23 With Chemotherapy Given Before Initial Surgery in Women With Advanced Stage Ovarian Cancer","CATALINA-4: Phase 1B\u002F2 Study of TORL-1-23 With Neoadjuvant Chemotherapy and Interval Cytoreductive Surgery in Newly Diagnosed Patients With Advanced Stage Ovarian Cancer","Inclusion Criteria:\n\n* Eastern Cooperative Oncology Group (ECOG) performance status 0 to 1\n* Histologically or cytologically confirmed diagnosis of epithelial ovarian, primary peritoneal or fallopian tubes cancer\n* FIGO Stage III or IV\n* Positive for claudin 6 (CLDN6) expression\n* Adequate organ function\n\nExclusion Criteria:\n\n* Clear cell, mucinous, sarcomatous, mixed histology, low-grade\u002Fborderline, or non-epithelial ovarian cancers\n* Prior systemic treatment for the disease under study\n* Prior surgery\n* Prior radiation therapy to the abdomen or pelvis\n* Current recipient or receipt within 5-half-lives of C1D1 of any of the following: chemotherapy, biologic\u002Ftargeted therapy, herbal medications or supplements, immunomodulator therapy for any disease indication.\n* History of noninfectious pneumonitis\u002Finterstitial lung disease (ILD) within 6 months of first dose of study drug.\n* Active, progressive, or symptomatic brain metastases\n* Participants considered poor medical risks due to serious, uncontrolled medical conditions, active infections, or nonmalignant systemic diseases\n* Pregnant or breastfeeding women","FEMALE","18 Years","75 Years",{"count":124,"type":125},60,"ESTIMATED","INTERVENTIONAL",[128,129],"PHASE1","PHASE2","A Phase 1B\u002F2 Study to Investigate the Safety and Efficacy of TORL-1-23 with Chemotherapy Given Before Initial Surgery in Women with Advanced Stage Ovarian Cancer",[132,133,134],"FIGO Stage III and IV Ovarian Cancer","Fallopian Tube Cancers","Primary Peritoneal Cancer","2026-07-09",{"date":137,"type":138},"2026-07-13","ACTUAL",{"date":140,"type":138},"2025-12-10",{"date":142,"type":125},"2028-01",{"name":5,"class":6},7]